Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis and psychiatric disorders: Comorbidity and sibling risk in a nationwide Swedish cohort.
Cerebral Cortex Involvement in Neuromyelitis Optica Spectrum Disorder.
Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort.
[Cognitive Impairment in Multiple Sclerosis].
Progressive degeneration of the retinal nerve fiber layer in patients with multiple sclerosis.
Humoral-Targeted Immunotherapies in Multiple Sclerosis.
Association of smoking with risk of multiple sclerosis: a population-based study.
Specialty drug coupons lower out-of-pocket costs and may improve adherence at the risk of increasing premiums.
Fingolimod (Gilenya) may improve the chances of conception in women with multiple sclerosis (MS) associated with secondary infertlity.
Pathological Involvement of Astrocyte-Derived Lipocalin-2 in the Demyelinating Optic Neuritis.
Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
Quality of life and employment in persons with multiple sclerosis.
Self-Efficacy as a Predictor of Self-Reported Physical, Cognitive, and Social Functioning in Multiple Sclerosis.
Correlations between serum uric Acid level and disease activity, intrathecal inflammation reactivity in patients with multiple sclerosis.
The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice.
Validity and reliability of the Greek version of the Modified Fatigue Impact Scale in multiple sclerosis patients.
Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum.
Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.
Microglia as a critical player in both developmental and late-life CNS pathologies.
Habitual Functional Electrical Stimulation Therapy Improves Gait Kinematics and Walking Performance, but Not Patient-Reported Functional Outcomes, of People with Multiple Sclerosis who Present with Foot-Drop.
Double Inversion Recovery Sequence of the Cervical Spinal Cord in Multiple Sclerosis and Related Inflammatory Diseases.
New analysis indicates that Novartis drug Gilenya shows significant early effect on reducing brain volume loss at 6 months
[Pay attention to the related advances of demyelinating diseases in the central nervous system].
Oligoclonal band status in scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.
Does the immune system act as a self-organized system in multiple sclerosis?

Pages